Abdurrahman Alpaslan ALKAN, Eyup DUZGUN, Ali OLGUN, Ece Ozdemir ZEYDANLİ, Murat KARAPAPAK

Inferonasal XEN gel stent implantation in a refractory glaucoma patient with failed multiple glaucoma filtration surgeries: Case report

A 59-year-old male with a history of diabetes mellitus and bilateral primary open angle glaucoma was referred to our clinic due to uncontrolled intraocular pressure (IOP) in the right eye. On examination, the visual acuity was 20/20 in both eyes and IOP was measured 22 mmHg in his right eye and 14 mmHg in his left eye despite maximal medical treatment. The patient had undergone two trabeculectomy and an EX-Press shunt surgery in the right eye previously. XEN gel stent (Allergan, Dublin, CA) implanted in the inferonasal quadrant due to the scarring in superior and nasal conjunctiva as a result of failed surgeries. The patient was followed up for 18 months with an IOP under 10 mmHg without any medication or a second intervention. XEN stent implantation may be considered as an effective option where other surgical techniques failed, and the conjunctiva is unsuitable in the superior quadrant.

PDF

___

1. Burr J, Azuara-Blanco A, Avenell A, et al. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev. 2012;9:CD004399.

2. Francis BA, Singh K, Lin SC, et al. Novel glaucoma procedures: A report by the American academy of ophthalmology. Ophthalmology. 2011;118:1466-80.

3. Lewis RA. Ab interno approach to the subconjunctival spaceusing a collagen glaucoma stent. J Cataract Refract Surg. 2014;40:1301-6.

4. Karimi A, Hopes M, Martin KR, et al. Efficacy and safety of the ab-interno Xen gel stent after failed trabeculectomy. J Glaucoma. 2018;27:864-8.

5. Sandhu S, Dorey MW. Xen ab interno gel stent use in a refractory glaucoma patient with previous filtration surgeries. J Glaucoma. 2018;27:59-60.

6. Hengerer FH, Kohnen T, Mueller M, et al. Ab interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results. J Glaucoma. 2017;26:1130-6.

7. Saheb H, Gedde SJ, Schiffman JC, et al.Tube versus trabeculectomy study group. outcomes of glaucoma reoperations in the tube versus trabeculectomy (TVT) study. Am J Ophthalmol. 2014;157:1179-89.

8. Tailor R, Lalias TA Case of refractory neovascular glaucoma treated with a XEN 45 implant. J Glaucoma. 2018;27:929-30.

9. Fea A, Cannizzo PM, Consolandi G, et al. Managing drawbacks in unconventional successful glaucoma surgery: A case report of stent exposure. Case Rep Ophthalmol Med. 2015;2015:847439.

10. Galal A, Bilgic A, Eltanamly R, Osman A. XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications. J Ophthalmol. 2017;2017:5457246.

11. Sekaran A, Karimi A, Lindfield D. Hypertrophic dysaesthetic blebs following ab-interno gel stent (Xen) glaucoma surgery: management and ‘redirect’ revision surgery. Clin Exp Ophthalmol. 2018;46:1093-5.

12. Fernandez-Garcia A, Romero C, Garzon N. “Dry Lake” technique for the treatment of hypertrophic bleb following XEN Gel Stent placement. Arch Soc Esp Oftalmol. 2015;90:536-8.

13. Budenz DL, Hoffman K, Zacchei A. Glaucoma filtering bleb dysesthesia. Am J Ophthalmol. 2001;131:626-30.

14. Kerr NM, Wang J, Sandhu A, et al. Ab Interno gel implant-associated bleb-related infection. Am J Ophthalmol. 2018;189:96-101.

15. Olgun A, Imamoglu S, Karapapak M, et al. Endophthalmitis after XEN gel stent implantation: 2 Cases. J Glaucoma. 2018;27:191-4.

16. Soltau JB, Rothman RF, Budenz DL, et al. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol. 2000;118:338-42.

17. Greenfield DS, Suner IJ, Miller MP, et al. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol. 1996;114:943-9.

18. Lenzhofer M, Strohmaier C, Hohensinn M, et al. Longitudinal bleb morphology in anterior segment OCT after minimally invasive transscleral ab interno glaucoma gel microstent implantation. Acta Ophthalmol. 2019;97:231-7.